Screening people’s genomes as part of routine primary care can spot genetic changes that may have important implications for health, a new study reports. The 90S study is the first to demonstrate that whole-genome sequencing (WGS) is feasible in a primary care setting and suggests it could have a role in detecting .
ASCO 2022: Screening of patients genomes for GPs to assess disease risk is feasible - The Institute of Cancer Research, London icr.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from icr.ac.uk Daily Mail and Mail on Sunday newspapers.
There is no NHS screening scheme for prostate cancer, but Ros Eeles of the Institute of Cancer Research hopes that will change. Around 50,000 men in the UK are diagnosed every year.